扁桃腺・アデノイド除去製品の世界市場-2023年～2030年

概要

世界の扁桃腺・アデノイド除去製品市場は、2022年に7億米ドルに達し、2023-2030年の予測期間中にCAGR 7.4％で成長し、2030年までに12億米ドルに達すると予測されています。

扁桃腺とアデノイドの除去の動きが、扁桃腺とアデノイドの外科的縮小に採用されています。扁桃腺とアデノイドは、それぞれ喉と鼻腔の奥に位置するリンパ系の一部です。扁桃腺とアデノイドは免疫プロセスの一部として機能していますが、扁桃腺が肥大化したり感染したりすると、呼吸障害、いびき、睡眠時無呼吸症候群を引き起こす可能性があります。

睡眠時無呼吸症候群や慢性扁桃炎など、扁桃腺やアデノイドに関連する疾患の有病率が上昇し、扁桃腺やアデノイドの切除手術件数が増加していることが市場を牽引しています。さらに、扁桃腺・アデノイド除去製品の開発における技術的進歩が、より安全で効果的なアプローチを導き、需要を押し上げています。

ダイナミクス

扁桃腺・アデノイド関連疾患の有病率の増加が扁桃腺・アデノイド除去製品市場の成長を牽引

扁桃腺・アデノイド関連疾患の有病率の増加は、予測期間中に世界の扁桃腺・アデノイド除去製品市場を押し上げると予想されています。例えば、National Center for Biotechnology Informationによると、2022年8月、米国では年間50万件以上の扁桃腺摘出手術が行われています。また、この地域は呼吸器感染症が多く、扁桃腺やアデノイド器官の外科的介入に再び寄与しています。

さらに、最近公表されたSPLIT調査では、ヒトヘルペスウイルス6（HHV6）、7（HHV7）、エプスタイン・バーウイルス（EBV）が扁桃組織で遭遇する代表的なヘルペスウイルスであった（50％、70％、70％）。ここでも、HHV6、HHV7、EBVおよびサイトメガロウイルス（CMV）が、選択的扁桃腺摘出術患者のアデノイド組織で検出されており、その優勢率はそれぞれ20％～77％、50％～77％、43％～73％および3％～50％の範囲で変動しています。

扁桃腺摘出術の調査活動の増加は、世界の扁桃腺・アデノイド除去製品市場に成長機会をもたらすと期待されています。

扁桃腺摘出術に関する調査活動の増加は、世界の扁桃腺・アデノイド除去製品市場に今後数年間の有望な成長機会をもたらすと期待されています。

例えば、2023年3月、UT Southwestern Medical Centerのグループによって指導された研究者は、小児扁桃腺摘出術後の出血の標準、高、低率の基準を決定する統計基準を開発しました。JAMA Otolaryngology-Head &Neck Surgery誌に発表されたこの結論により、医師や病院は、米国で3番目に代表的な小児外科手術の成績を向上させることができます。

扁桃腺摘出手術の合併症は予測期間中、世界の扁桃腺・アデノイド除去製品市場を妨げると予想されます。

扁桃腺摘出術の典型的な合併症には、術後感染、出血、舌浮腫、舌咽神経損傷、頸動脈損傷などがあります。扁桃腺摘出術の非常に典型的ですが、深刻な合併症は遅発性出血であり、これは全患者の2～4％に生じます。さらに、扁桃腺摘出術の後遺症として予想されるのは疼痛であり、一般的に7～10日間持続し、その強さは中等度から重度まで様々です。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 扁桃腺・アデノイド関連疾患の有病率の増加
    • 市場開拓
  • 抑制要因
    • 手術合併症の脅威
  • 機会
    • 調査活動の増加
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 COVID-19分析

第7章 製品タイプ別

• 扁桃腺除去製品
  • 鉗子
  • ワイヤーループ
  • ハサミ
• アデノイド除去製品
  • マイクロデブライダー

第8章 技術別

• コブレーション
• 電気メス（ECT）
• ハーモニックスカルペル
• その他

第9章 エンドユーザー別

• 病院
• 専門クリニック
• 外来手術センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • その他アジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Medtronic
  • 企業概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な動向
• BAUSCH & LOMB INCORPORATED
• Olympus America
• New Med Instruments
• Medelecsurgical
• Smith & Nephew
• Advin Health Care
• Deluxe Scientific Surgico Pvt Ltd.
• EON Meditech
• Integra LifeSciences

第13章 付録

Overview

Global Tonsil and Adenoid Removal Products market reached US$ 0.7 billion in 2022 and is expected to reach US$ 1.2 billion by 2030 growing with a CAGR of 7.4% during the forecast period 2023-2030.

Tonsil and adenoid removal developments are employed in the surgical reduction of tonsils and adenoids. Tonsils and adenoids are parts of the lymphatic system situated in the rear of the throat and nasal cavity, respectively. They function as part of the immune process, though when they become broadened or infected, they can lead to breathing problems, snoring, and sleep apnea.

The market is driven by the rising prevalence of tonsils and adenoid-associated conditions, including sleep apnea and chronic tonsillitis leading to incrase in number of tonsil and adenoid removal procedures. Furthermore, the demand is pushed by technological advances in tonsil and adenoid removal product developments, which have guided securer and more efficacious approaches.

Dynamics

The Increasing Prevalence of Tonsils and Adenoid-Associated Conditions Drive the Growth of the Tonsil and Adenoid Removal Products Market

The increasing prevalence of tonsils and adenoid-associated conditions is expected to boost the global tonsil and adenoid removal products market during the forecast period. For instance, according to the National Center for Biotechnology Information, in August 2022, more than 500,000 operations of tonsillectomies were conducted annually in the United States. The region also has a high preponderance of respiratory infections which again contributes to the surgical interventions of the tonsil and adenoid organs.

Moreover, in the lately publicized SPLIT investigation, human herpesviruses 6 (HHV6), 7 (HHV7), and Epstein-Barr virus (EBV) were the highly typical herpesviruses encountered in the tonsil tissue (50%, 70%, 70%). Again, HHV6, HHV7, EBV, and cytomegalovirus (CMV) have been caught in adenoid tissue of elective adenotonsillectomy patients, the preponderance rates fluctuating in the scopes of 20%-77%, 50%-77%, 43%-73%, and 3%-50%, respectively.

The Increasing Research Activities for Tonsillectomy Procedures are Expected to Present the Global Tonsil and Adenoid Removal Products Market With Growth Opportunities

Increasing research activities for tonsillectomy procedures are expected to present the global tonsil and adenoid removal products market with prospective growth opportunities in the forthcoming years.

For instance, in March 2023 researchers guided by a group at UT Southwestern Medical Center developed a statistical standard to determine criteria for standard, high, or low rates of bleeding post-pediatric tonsillectomies. The conclusions, published in JAMA Otolaryngology-Head & Neck Surgery, could allow doctors and hospitals to enhance results for the third-most typical pediatric surgery in the U.S.

The Tonsillectomy Surgery Complications is Expected to Hamper the Global Tonsil and Adenoid Removal Products Market During the Forecast Period

Some typical complications of tonsillectomy are postoperative infection, bleeding, edema of the tongue, glossopharyngeal nerve injury, and carotid artery damage. The highly typical but serious intricacy of tonsillectomy is delayed hemorrhage, which transpires in 2% to 4% of all patients. Further, an anticipated sequela of the process is pain, which commonly stays from 7 to 10 days and varies from moderate to severe in intensity.

Segment Analysis

The global tonsil and adenoid removal products market is segmented based on product type, technology, end-users, and region.

The Coblation Technique Technology Type is Estimated to Dominate the Global Tonsil and Adenoid Removal Products Market

The coblation technique technology type is expected to hold around 37.8% of the global market share owing to improved outcomes from this technique compared to others. For instance, in March 2023, Smith+Nephew, the multinational medical technology corporation, declared the outcomes from a recent scientific investigation that demonstrates its COBLATION Intracapsular Tonsillectomy (CIT) procedure can guide to enhanced post-operative results in patients versus total tonsillectomy procedures. The investigation was lately publicized online by OTO Open Journal titled The Open Access Journal of the American Academy of Otolaryngology-Head and Neck Surgery Foundation.

Geographical Penetration

North America is Estimated to hold Approximately 38.8% of the Market Share by 2030, Owing to Increasing Cases of Tonsils and Adinosides Associated Disorders in this Region

Owing to the increasing cases of tonsils and adinosides associated disorders in the North America region, it is estimated to dominate the global market holding around 38.3% of the market by 2030. For instance, according to the American Academy of Otolaryngology-Head and Neck Surgery, a tonsillectomy is one of the most typically conducted surgical operations in United states. More than 500,000 surgeries are performed yearly in children below 15 years of age.

Two standard causes for this surgery includes sleep-disordered breathing and recurrent throat disorders. Moreover, sleep apnea is predominant and diagnosed in around 18 million Americans alone. This statistic signifies that roughly 1 in every 15 Americans, or 6.62% of the total American population have sleep apnea. Further, approximately 2% of ambulatory patient visits in the United States are because of sore throat. Though it is highly expected in winter and early spring, the condition can transpire at any period during the year. The group A beta-hemolytic Streptococcus GABHS makes up for 5% to 15% of adults with pharyngitis and 15% to 30% of patients between the years of five and fifteen.

Competitive Landscape

The major global players in the tonsil & adenoid removal products market include: Medtronic, BAUSCH & LOMB INCORPORATED, Olympus America, New Med Instruments, medelecsurgical, Smith & Nephew, Advin Health Care, and Deluxe Scientific Surgico Pvt Ltd, among others.

COVID-19 Impact Analysis

Russia-Ukraine Conflict Analysis

The Russia-Ukraine conflict is assumed to have had a very moderate impact on the global tonsil and adenoid removal products market, as this region lacks primary market players. However, during the 3 months of full-scale warfare, Russians sabotaged over 600 infirmaries and massacred at least 12 medics. Access to health care is majorly affected because of security considerations, limited mobility, damaged supply chains, and mass population eviction. In addition, the import and export of fundamental materials' significance is expected to slightly impact the global tonsil & adenoid removal products market growth in the forecast period.

By Product Type

• Tonsils Removal Products
  • Forceps
  • Wire loop
  • Scissors

• Adenoid Removal Products
  • Microdebrider

By Technology

• Coblation
• Electrocautery (ECT)
• Harmonic scalpel
• Other

By End-Users

• Hospital
• Specialty Clinics
• Ambulatory surgical centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico

• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe

• South America
  • Brazil
  • Argentina
  • Rest of South America

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific

• Middle East and Africa

Key Developments

• In September 2022, Olympus America introduced its state-of-the-art energy device accurate dissection equipment, THUNDERBEAT Open Fine Jaw Type X surgical energy instruments. It delivers fine dissection utilizing cutting-edge bipolar energy.
• In February 2022 Pristyn Care, a health technology, and secondary-care surgeries start-up, declared that it had expanded its surgical centers to 800 in India, in 2021.

Why Purchase the Report?

• To visualize the global tonsil and adenoid removal products market segmentation based on product type, technology, end-users and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous tonsil and adenoid removal products market-level data points with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available in excel consisting of key products of all the major players.

The global tonsil and adenoid removal products market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Technology
• 3.3. Snippet by End-Users
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Prevalence of Tonsils and Adenoids Associated Conditions
    • 4.1.1.2. Market Developments
  • 4.1.2. Restraints
    • 4.1.2.1. Threat of Surgical Complications
  • 4.1.3. Opportunity
    • 4.1.3.1. Increasing Research Activities
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers' Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Tonsils Removal Products *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.2.3. Forceps
  • 7.2.4. Wire loop
  • 7.2.5. Scissors
• 7.3. Adenoid Removal Products
  • 7.3.1. Microdebrider

8. By Technology

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 8.1.2. Market Attractiveness Index, By Technology
• 8.2. Coblation*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Electrocautery (ECT)
• 8.4. Harmonic scalpel
• 8.5. Others

9. By End-Users

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
  • 9.1.2. Market Attractiveness Index, By End-Users
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Specialty Clinics
• 9.4. Ambulatory surgical centers
• 9.5. Other

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. The U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Spain
    • 10.3.6.5. Italy
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan

Australia

• 10.5.6.4. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-Users

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Medtronic *
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. BAUSCH & LOMB INCORPORATED
• 12.3. Olympus America
• 12.4. New Med Instruments
• 12.5. Medelecsurgical
• 12.6. Smith & Nephew
• 12.7. Advin Health Care
• 12.8. Deluxe Scientific Surgico Pvt Ltd.
• 12.9. EON Meditech
• 12.10. Integra LifeSciences

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Product
• 13.2. Contact Us